, Volume 9, Issue 3, pp 230-241
Date: 31 Jul 2013

The Continuum of Care in Chemotherapy Approach to Metastatic Colorectal Cancer

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Colorectal cancer is a major public health problem and, despite recent advances in treatment, most patients with metastatic colorectal cancer (mCRC) will succumb to their disease. Yet, survival of patients with mCRC has markedly improved as the number of effective cytotoxic and novel targeted agents has grown. However, the best order and combination of these agents, and the optimum duration of treatment with the purpose of maximizing efficacy while minimizing toxicity are not fully established.